BioCentury
ARTICLE | Clinical News

Smart Anti-L-Selectin antibody: PDLI partner Scil Biomedicals GmbH (Martinsried, Germany) completed enrollment of 21 patients with moderate-to-severe plaque pso

April 8, 2002 7:00 AM UTC

Protein Design Labs Inc. (PDLI), Fremont, Calif. Product: Smart Anti-L-Selectin antibody Business: Autoimmune/Inflammation Therapeutic category: Antibody, Immune modulation Target: L-Selection Descrip...